Literature DB >> 28734746

Spina Bifida Management.

Leslie A Phillips1, Justin M Burton1, Sarah Helen Evans1.   

Abstract

Myelomeningocele, commonly known as spina bifida, is a birth defect in which the spinal cord does not develop properly due to incomplete closure of the neural tube at 28 days of gestation. With advances in treatment modalities, technologies, and medical knowledge, people with spina bifida in the United States are living well into adulthood. Myelomeningocele management includes life-long comprehensive neurologic, urologic, musculoskeletal, skin, and habilitation management. We describe approaches to the same, with an emphasis on the signs and symptoms of medical urgencies and emergencies of which every pediatrician must be aware.
Copyright © 2017 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28734746     DOI: 10.1016/j.cppeds.2017.06.007

Source DB:  PubMed          Journal:  Curr Probl Pediatr Adolesc Health Care        ISSN: 1538-3199


  3 in total

1.  Ambulation, lesion level, and health-related quality of life in children with myelomeningocele.

Authors:  Ebru Şeker Abanoz; Meral Özmen; Mine Çalışkan; Gülbin Gökçay; Nur Aydınlı
Journal:  Childs Nerv Syst       Date:  2019-08-19       Impact factor: 1.475

2.  Pediatric Spina Bifida and Spinal Cord Injury.

Authors:  Joslyn Gober; Sruthi P Thomas; David R Gater
Journal:  J Pers Med       Date:  2022-06-17

3.  Serum exosomal coronin 1A and dynamin 2 as neural tube defect biomarkers.

Authors:  Yanfu Wang; Ling Ma; Shanshan Jia; Dan Liu; Hui Gu; Xiaowei Wei; Wei Ma; Wenting Luo; Yuzuo Bai; Weilin Wang; Zhengwei Yuan
Journal:  J Mol Med (Berl)       Date:  2022-08-01       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.